Cargando…

Mechanisms of resistance to EGFR-targeted therapies in colorectal cancer: more than just genetics

The development of acquired resistance to anti-EGFR therapies remains poorly understood, with most research to date exploring, and trying to overcome, various genomic mechanisms of resistance. However, recent work supports a model of resistance whereby transcriptomic mechanisms of resistance predomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Parseghian, Christine, Eluri, Madhulika, Kopetz, Scott, Raghav, Kanwal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542118/
https://www.ncbi.nlm.nih.gov/pubmed/37791069
http://dx.doi.org/10.3389/fcell.2023.1176657

Ejemplares similares